Sigmund Silber, MD, PhD Professor of Medicine
FESC, FACC, FAHA
Cardiologist

365

Silber S, Parhofer K.
Is the Distinction Between Primary and Secondary Prevention Still Appropriate?
MMW Fortschr Med. 2026; 168:48-51
your personal reprint



364

Silber S.
Combining Lipid-Lowering Therapies Wisely:
What LDL Cholesterol Targets Should Be Used?
Why Do Primary Care and Cardiology Practices Use Different Target Levels?

Ärzte Zeitung No. 8, April 30, 2026; 20-24
your personal reprint

References



363

Silber S, Schneider T, Mehilli J, Rolf A.
Assessment of Noninvasive Coronary CT Angiography (CCTA) as a Newly Covered Benefit Under Germany's Statutory Health Insurance System:
Which Patients Are Eligible? Which Are Not?

What Needs to Be Considered? – DGK Position Statement
From the Commission for Clinical Cardiovascular Medicine in cooperation with Cluster B “Imaging Modalities” and the AGIK
Die Kardiologie 2026; 20:190–203
your personal reprint

Coverage in Cardio News:
CCTA Coverage Under Statutory Health Insurance – DGK Position Statement
Cardio News, March 3–6, 2026

Quick Dive on HERZ MEDIZIN:
Critical Appraisal of Noninvasive Coronary CT Angiography (CCTA)
as a link or as a PDF



362

Lindner O, Goetz C, Bengel F, Linke A, Maier A, Papathanasiou M, Silber S, Rischpler C, Greulich S, Bucerius J.
Nuclear Cardiology – Current Status of Clinical Practice
Consensus Paper of the DGK and DGN
Die Kardiologie 2026; 20:46-53
your personal reprint

Coverage in Cardio News:
New Consensus Paper on Nuclear Cardiology
Cardio News, March 3–6, 2026



361

Silber S, Keller M, Rippel M.
Safety and tolerability of pharmacologic stress with the selective A2A adenosine receptor agonist regadenoson for the assessment of myocardial ischemia:
results from 5780 consecutive patients in a cardiology practice

Clinical Research in Cardiology, March 2026,
online, https://doi.org/10.1007/s00392-026-02871-0
your personal reprint



360

Klier I, Silber S.
CME Focus
Unexplained Syncope and Congenital Long QT Syndrome
MMW Fortschr Med. 2026; 168: (Suppl 1), 22–25
your personal reprint



359

Silber S, Keller M.
Suspected CAD: What Is the Best Current Approach in General Practice?
MMW Fortschr Med. 2025;167:38–42
your personal reprint


358

Silber S.
Stable CAD: What Needs to be Improved in Germany
Editorial for the special issue "Chronic Coronary Syndrome"
MMW Fortschr Med. 2025;167:5
your personal reprint


357

Bengel F, Bucerius J, Burchert W, Dörr R, Hacker M, Lindner O*, Rischpler C, Rudolph V, Schäfer W, Schäfers M, Schmidt M, Silber S, vom Dahl J,
* lead author
DGN (German Society of Nuclear Medicine) Recommendation (S1 Guideline)
Myocardial Perfusion SPECT(-CT)

Conflicts of Interest

Published online by AWMF (Association of the Scientific Medical Societies in Germany)
July 2023


356

Lindner O, Schäfer W, Rischpler C, Silber S, Burchert W.
Myocardial perfusion SPECT in Germany from 2012 to 2021:
insights into development and quality indicators

European Journal of Nuclear Medicine and Molecular Imaging 2023, 50:1621–1628
your personal reprint


355

Lindner O, Schaefer WM, Silber S, Rischpler C, Burchert W.
Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany:
Results of the 9th Survey

Nuklearmedizin 2023; 62: 235–243
your personal reprint


354

Korosoglou G, Thiele H, Silber S, Schmitz T, Tiefenbacher C, Landmesser U, Helfen A, Nowak B, Bernhardt P, Baldus S, Rolf A.
Guideline-based and needs-oriented diagnostics for symptomatic obstructive coronary artery disease using cardiac CT and MRI
Position paper of the German Society of Cardiology (DGK)

Die Kardiologie, 2023, 17:406–417
your personal reprint


353

Zippel-Schultz B, Silber S, Helms TM.
Do telemedicine centers improve prognosis in heart failure?
MMW Fortschr Med. 2023;165:50–52
your personal reprint


352

Silber S, Keller M.
“Normal cardiac catheterization” despite angina and myocardial ischemia:
INOCA often overlooked

MMW Fortschr Med. 2023;165:34–37
Private reprint


351

Silber, S
Editorial
on the focus topic coronary artery disease (CAD)
CAD: A chameleon with many faces
MMW Fortschr Med. 2023;165:5
Private reprint


350

Cutlip, DE, Jauhar, R, Meraj P, Garratt KN, Novack V, Novack L, Maillard L, Erglis A, Stoler R, Barakat M, Silber S. for the PzF SHIELD Trial Investigators
Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System
Cardiovasc Revasc Med 2022 Vol. 41 Pages 76-80
your personal reprint


349

Silber S.
[Determination of the individual risk of a heart attack, stroke or cardiovascular death in apparently healthy persons]
MMW Fortschr Med. 2022;164:32-36
(in German language)
your personal reprint


348

Silber S. Editorial
[Prognosis of Heart Failure Worse than Cancer]
MMW Fortschr Med. 2022;164:5
(in German language)
your personal reprint


347

Silber S.
[The new ESC guideline for heart failure therapy: What has changed for general practice?]
MMW Fortschr Med. 2022;164:40-43
(in German language)
your personal reprint


346

Keller, M, Silber S.
[Amyloidosis of the heart: When do general practitioners have to think about it?]
MMW Fortschr Med. 2021;163:54-56
(in German language)
your personal reprint


345

Kelbaek H, Yeh RW, Engstrom T, Neumann FJ, Serruys PW, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S.
Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions
EuroIntervention. 2021, 16: 1326 -1332
your personal reprint


344

Cortes C, Chu M, Schincariol M, Martinez-Hervas Alonso MA, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutierrez-Chico JL.
Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study
EuroIntervention. 2021, 17: e140 - e148
your personal reprint


343

Cortes C, Johnson TW, Silber S, Buszman PP, Poerner TC, Lavarra F, Ibanez B, Kim Y, Mischke K, Jaguszewski M, Gutierrez-Chico JL.
ISCHEMIA trial: The long-awaited evidence to confirm our prejudices
Cardiol J. 2020;27:336-341
your personal reprint


342

Bengel FM, Burchert W, Dörr R, Hacker M, Kaufmann P, Rischpler C, Schäfer W, Schäfers M, Silber S, Zimmermann R, Buechel RR
[The Role of Nuclear Cardiology in Cardiac Amyloidosis]
Der Kardiologe, 2020, 14: 42-45
(in German language)
your personal reprint

Reply: Frey N, Bauersachs J, v. Knobelsdorff F, Bönner F, Yilmaz A Kommentierungen zum Positionspapier der DGK Der Kardiologe, 2020, 14: 46-50
(in German language)
your personal reprint


341

Figulla HR, Lauten A, Maier LS, Sechtem U, Silber S, Thiele H.
[Percutaneous Coronary Intervention in Stable Coronary Heart Disease - Is Less More?]
Deutsches Arzteblatt international. 2020;117:137-144
(in German language)
your personal reprint


340

Haude M, Lee SWL, Worthley SG, Silber S, Verheye S, Rosli MA, Botelho R, Sim KH, Abizaid A, Mehran R, Investigators RT.
The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent
Catheter Cardiovasc Interv. 2020;95:1076-1084
your personal reprint